ASSESSING THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY THE COMBINED PATTERN OF RETINOLBINDING PROTEIN-4, HIGH MOLECULAR WEIGHT ADIPONECTIN AND BODY MASS INDEX
Author(s) -
Л. А. Атраментова,
Н. А. Кравчун,
В. В. Полторак,
Maryana Gorshunska,
E. Jаnsen,
N. S. Krasova,
Жанна Лещенко,
A. I. Gladkih,
T. V. Tyzhnenko,
Olga Plohotnichenko,
Y. A. Opaleiko,
A. K. Pochernyaev,
I. P. Dunaeva
Publication year - 2021
Publication title -
problems of endocrine pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 2
eISSN - 2518-1432
pISSN - 2227-4782
DOI - 10.21856/j-pep.2015.3.02
Subject(s) - adiponectin , body mass index , medicine , type 2 diabetes mellitus , fatty liver , endocrinology , nonalcoholic fatty liver disease , diabetes mellitus , obesity , disease , gastroenterology , insulin resistance
The diagnostic model to highlight the high-risk groups of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus by the level of retinol-binding protein-4, high molecular weight adiponectin and body mass index using discriminant analysis was developed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom